AR012556A1 - Un derivado de carboxamidas de 2-[2'-hidroxi-3'-feniltiometil-4'-aza-5'-(2"-metil-3"-hidroxifenil)pentil]-decahidroisoquinolina, una sal de dicho compuesto derivado y composiciones farmacéuticas. - Google Patents

Un derivado de carboxamidas de 2-[2'-hidroxi-3'-feniltiometil-4'-aza-5'-(2"-metil-3"-hidroxifenil)pentil]-decahidroisoquinolina, una sal de dicho compuesto derivado y composiciones farmacéuticas.

Info

Publication number
AR012556A1
AR012556A1 ARP980101104A ARP980101104A AR012556A1 AR 012556 A1 AR012556 A1 AR 012556A1 AR P980101104 A ARP980101104 A AR P980101104A AR P980101104 A ARP980101104 A AR P980101104A AR 012556 A1 AR012556 A1 AR 012556A1
Authority
AR
Argentina
Prior art keywords
derivative
phenyltiomethyl
carboxamid
penyl
aza
Prior art date
Application number
ARP980101104A
Other languages
English (en)
Spanish (es)
Original Assignee
Japan Tobacco Inc
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc, Agouron Pharma filed Critical Japan Tobacco Inc
Publication of AR012556A1 publication Critical patent/AR012556A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
ARP980101104A 1997-03-13 1998-03-12 Un derivado de carboxamidas de 2-[2'-hidroxi-3'-feniltiometil-4'-aza-5'-(2"-metil-3"-hidroxifenil)pentil]-decahidroisoquinolina, una sal de dicho compuesto derivado y composiciones farmacéuticas. AR012556A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81595197A 1997-03-13 1997-03-13

Publications (1)

Publication Number Publication Date
AR012556A1 true AR012556A1 (es) 2000-11-08

Family

ID=25219265

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101104A AR012556A1 (es) 1997-03-13 1998-03-12 Un derivado de carboxamidas de 2-[2'-hidroxi-3'-feniltiometil-4'-aza-5'-(2"-metil-3"-hidroxifenil)pentil]-decahidroisoquinolina, una sal de dicho compuesto derivado y composiciones farmacéuticas.

Country Status (35)

Country Link
EP (1) EP0970055A2 (uk)
JP (1) JP2001516350A (uk)
KR (1) KR100511089B1 (uk)
CN (1) CN1179948C (uk)
AP (1) AP1358A (uk)
AR (1) AR012556A1 (uk)
AU (1) AU743078B2 (uk)
BG (1) BG63540B1 (uk)
BR (1) BR9808867A (uk)
CA (1) CA2284163A1 (uk)
CO (1) CO4940496A1 (uk)
CZ (1) CZ296647B6 (uk)
EA (1) EA002378B1 (uk)
EE (1) EE04114B1 (uk)
GE (1) GEP20022764B (uk)
HR (1) HRP980112A2 (uk)
HU (1) HUP0001380A3 (uk)
IL (2) IL131870A0 (uk)
IS (1) IS5176A (uk)
MX (1) MXPA99008395A (uk)
MY (1) MY117535A (uk)
NO (1) NO315555B1 (uk)
NZ (1) NZ337706A (uk)
OA (1) OA11196A (uk)
PA (1) PA8448801A1 (uk)
PE (1) PE58799A1 (uk)
PL (1) PL192786B1 (uk)
SA (1) SA98181116B1 (uk)
SK (1) SK283636B6 (uk)
SV (1) SV1998000038A (uk)
TR (1) TR199902508T2 (uk)
TW (1) TW200517112A (uk)
UA (1) UA57772C2 (uk)
WO (1) WO1998040357A2 (uk)
ZA (1) ZA982047B (uk)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
SV1998000038A (es) 1999-02-15
MY117535A (en) 2004-07-31
IL131870A0 (en) 2001-03-19
CN1253548A (zh) 2000-05-17
NO994415D0 (no) 1999-09-10
ZA982047B (en) 1998-09-28
HUP0001380A3 (en) 2001-12-28
TR199902508T2 (xx) 2000-02-21
EE04114B1 (et) 2003-08-15
SK283636B6 (sk) 2003-11-04
CZ319199A3 (cs) 2000-06-14
HUP0001380A2 (hu) 2000-09-28
IS5176A (is) 1999-09-10
CN1179948C (zh) 2004-12-15
SA98181116B1 (ar) 2006-10-04
EA002378B1 (ru) 2002-04-25
BG103727A (en) 2000-04-28
KR100511089B1 (ko) 2005-08-31
AU6457598A (en) 1998-09-29
WO1998040357A3 (en) 1998-11-26
PA8448801A1 (es) 2000-05-24
CO4940496A1 (es) 2000-07-24
MXPA99008395A (es) 2003-08-12
NO315555B1 (no) 2003-09-22
KR20000076236A (ko) 2000-12-26
SK122299A3 (en) 2000-05-16
PL192786B1 (pl) 2006-12-29
BR9808867A (pt) 2000-07-11
PL335672A1 (en) 2000-05-08
EP0970055A2 (en) 2000-01-12
AP9901648A0 (en) 1999-09-30
AU743078B2 (en) 2002-01-17
PE58799A1 (es) 1999-07-12
HRP980112A2 (en) 1998-12-31
UA57772C2 (uk) 2003-07-15
EA199900823A1 (ru) 2000-04-24
TW200517112A (en) 2005-06-01
JP2001516350A (ja) 2001-09-25
CZ296647B6 (cs) 2006-05-17
BG63540B1 (bg) 2002-04-30
AP1358A (en) 2004-12-03
CA2284163A1 (en) 1998-09-17
NZ337706A (en) 2001-04-27
WO1998040357A2 (en) 1998-09-17
IL131870A (en) 2006-04-10
NO994415L (no) 1999-11-10
OA11196A (en) 2003-05-21
EE9900416A (et) 2000-04-17
GEP20022764B (en) 2002-08-26

Similar Documents

Publication Publication Date Title
DZ2514A1 (fr) Dérivés substitués en c-4'de9-désoxo-9a-aza-9a-homoérythromycine a.
DE59105121D1 (de) Desodorierende kosmetische mittel.
NL190757C (nl) 4-(3-Chloorfenyl)-1-piperazinylpropyl gesubstitueerde-1,2,4-triazool-3-on verbindingen met antidepressieve werking en farmaceutische preparaten daarvan.
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
HUP9902092A3 (en) Metalloproteinase inhibitor benzenesulfonamide derivatives, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds
MA26507A1 (fr) Compositions pharmaceutiques d'aerosol
IT1297193B1 (it) Composizione per la lotta contro parassiti di animali.
DE58906867D1 (de) Wässrige Dispersion von 2-(2'-Hydroxyphenyl-)benzotriazolen.
DE69130327D1 (de) Stabilisierte, insektizide, nematode-enthaltende mittel
BR9408494A (pt) Preparações para o branqueamento dos dentes
DE69518464D1 (de) Verdickte kosmetische Zubereitungen
FI972432A (fi) Titaani(II)- tai sirkonium(II)-kompleksien parannettu valmistus
FI952682A (fi) Insektisidisiä 5-substituoituja 2,4-diamiinipyrimidiinijohdannaisia
MA23779A1 (fr) Compose 9-substitue 2-(2-n-alkoxyphenyl) - purine -6- ones
DE58904470D1 (de) Triazindion-derivate enthaltendes mittel gegen fischparasiten.
DE59002510D1 (de) Mittel gegen Keratinschädlinge.
IT1302564B1 (it) Immunosaggio di polarizzazione di fluorescenza perfezionato.
DE69812805D1 (de) Fungizide 2,6,6'-Trimethylbenzophenone
BR9605046B1 (pt) compostos n-(pirimidinl)-benzenossulfonamida e preparação farmacêutica contendo as mesmas.
DE59909255D1 (de) Kosmetische zubereitungen
ES2015566B3 (es) Nuevos compuestos tio que tienen actividad fungicida.
AR012556A1 (es) Un derivado de carboxamidas de 2-[2'-hidroxi-3'-feniltiometil-4'-aza-5'-(2"-metil-3"-hidroxifenil)pentil]-decahidroisoquinolina, una sal de dicho compuesto derivado y composiciones farmacéuticas.
TR27782A (tr) Bir fenilbenzamid'e dayanan fungisidal birlesimler.
TR27485A (tr) Aktif muhteva olarak bir tür piretroid bilesigini iceren düsük iritasyonlu bir sampuan kompozisyonu.

Legal Events

Date Code Title Description
FG Grant, registration